BU08028   Click here for help

GtoPdb Ligand ID: 9294

Synonyms: compound 1b [PMID: 21866885]
Compound class: Synthetic organic
Comment: BU08028 is a novel research compound that provides the pain relief of opiates, without their addictive effects in mouse models of acute pain and cocaine-induced reward [1-2]. Structurally it is a derivative of buprenorphine, with only the addition of an additional methylene group at the C20 substituent. Increasing affinity for the NOP receptor is predicted to reduce the behavioural side-effects associated with buprenorphine.
Note that the compound referred to as 1b in [1] has a marginally different stereo compared to the same compound (named as BUB8028) in [2], with identical data provided for 1b and BUB8028 in both articles. Compound 1b resolves to PubChem CID 56664973. We have chosen to link to CID 50922685 as the specified stereochemistry of this is identical to that of buprenorphine.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 62.16
Molecular weight 481.32
XLogP 4.13
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COC12CCC3(CC1C(C(CC)(C)C)(O)C)C14C2Oc2c4c(CC3N(CC1)CC1CC1)ccc2O
Isomeric SMILES CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(CC)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O
InChI InChI=1S/C30H43NO4/c1-6-26(2,3)27(4,33)21-16-28-11-12-30(21,34-5)25-29(28)13-14-31(17-18-7-8-18)22(28)15-19-9-10-20(32)24(35-25)23(19)29/h9-10,18,21-22,25,32-33H,6-8,11-17H2,1-5H3/t21-,22-,25-,27+,28-,29+,30-/m1/s1
InChI Key HBENZIXOGRCSQN-VQWWACLZSA-N

For advanced searching click here to open chemical structure editor

Similar Ligands Click here for help
[3H]diprenorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
dihydromorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
diprenorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
etorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
morphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
nalmefene
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
nalorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
normorphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
β-FNA
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
BNTX
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
naloxone
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
naltrexone
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
nalfurafine
Click here for ligand page
Targets
κ receptor
nalbuphine
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
naloxone benzoylhydrazone
Click here for ligand page
Targets
κ receptor; μ receptor
(+)-naloxone
Click here for ligand page
Targets
κ receptor
buprenorphine
Click here for ligand page
Targets
κ receptor; μ receptor
codeine
Click here for ligand page
Targets
μ receptor; CYP3A4
[3H]naloxone
Click here for ligand page
Targets
μ receptor
naloxonazine
Click here for ligand page
Targets
μ receptor
hydrocodone
Click here for ligand page
Targets
κ receptor; μ receptor
hydromorphone
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
oxycodone
Click here for ligand page
oxymorphone
Click here for ligand page
naloxegol
Click here for ligand page
methylnaltrexone
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
dihydrocodeine
Click here for ligand page
diamorphine
Click here for ligand page
pholcodine
Click here for ligand page
BU72
Click here for ligand page
Targets
μ receptor
MP1104
Click here for ligand page
Targets
κ receptor
NFP
Click here for ligand page
Targets
δ receptor; κ receptor; μ receptor
oxycodegol
Click here for ligand page
Targets
δ receptor; μ receptor
SRI22141
Click here for ligand page
Targets
δ receptor; μ receptor